Vial

Vial, founded in 2020, is a biotechnology research company where we develop biologics and RNA therapeutics. We are working on a pipeline of treatments for areas where medical options are currently lacking.

Our pipeline includes INHBE siRNA for obesity and other heart-related conditions, IL-13 x TSLP for atopic dermatitis, asthma, and chronic sinusitis, TMPRSS6 for polycythemia vera, Myostatin (GDF8) for obesity,

We combine a computational discovery engine with highly automated clinical trials to conduct our research. We have raised over $100M from investors including General Catalyst, Box Group, and Byers Capital.

Our mission at Vial is to rethink drug development by designing for large scale and helping scientists find cures for human diseases through quicker, more efficient clinical trials.

Our core values are:

• ‘Do it Right’
• ‘Ship It’
• ‘Be Intellectually Honest’
• ‘Writing is a Superpower’
• ‘ABCD (Always Be Connecting Dots)’
• ‘Structure It’
• ‘Have Fun!’

We are a remote-first company headquartered in San Francisco, CA, with 51-200 employees. Our team collaborates across various time zones and locations, requiring at least two hours of overlap with PST for joint work.

We cultivate an inclusive culture that ensures fair access to opportunities. We value natural curiosity, autonomy, developing expertise in our work, and moving quickly while staying humble. We encourage structured thinking and integrity in our work environment.

We offer unlimited vacation, a full benefits package including medical, dental, and vision coverage, and paid parental leave. We also maintain a remote-first work culture.